Abbvie finalizes deal to buy Allergan for $63 billion
A mega deal in pharma. Abbvie is buying botox-maker Allergan for $63 billion. The deal’s worth about $188 a share in cash and stock, representing a 45% premium over Allergan’s closing price yesterday. Yahoo Finance’s Dan Roberts joins Seana Smith.